Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 36:
37. The compound of claim 35, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is 3- to 12-membered heterocyclyl, wherein the 3- to 12-membered heterocyclyl is substituted by 1, 2, 3, 4, or 5 independently selected R2c substituents; and
each R2c is independently halogen, CN, C1-C6 alkyl, C(O)R5, C(O)OR5, OR5, ═O, S(O)2R5, C6-C14 aryl, or 5- to 10-membered heteroaryl, wherein each C1-C6 alkyl is optionally and independently substituted by 1 or more independently selected R4a substituents.